Sign In
Buy PFE
$27.05
+0.290 (+1.08%)
At Close: Aug 10, 2026
AI Bubble Risks Make Dividend Stocks Attractive Again
01:03pm, Saturday, 18'th Jul 2026
I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates qualit
Pfizer Paid Out $14.6 Billion in Dividends Over the Last 18 Months. Can It Keep This Up Through the Patent Cliff?
09:15am, Saturday, 18'th Jul 2026
Pfizer is one of the world's largest drug makers. The company is facing typical industry headwinds as it seeks new drugs to replace older ones.
Dividend Champion, Contender, And Challenger Highlights: Week Of July 19
11:12pm, Friday, 17'th Jul 2026
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
3 High-Yield Dividend Stocks to Buy and Hold
01:00am, Friday, 17'th Jul 2026
All three can be bought on the dip.
Pfizer Stock Below 50-Day and 200-Day SMA: Buy the Dip or Exit Now?
11:45am, Thursday, 16'th Jul 2026
PFE trades below key moving averages as investors weigh fading COVID sales against pipeline growth, acquisitions and a low valuation with a high dividend.
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle (“LNP”) technology against Pfizer and Bio
Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King
12:27pm, Wednesday, 15'th Jul 2026
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Pfizer (NYSE:PFE) both closed Q1 2026 with earnings beats, yet their post-report stories look nothing alike.
Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?
09:10am, Wednesday, 15'th Jul 2026
Pfizer (NYSE:PFE | PFE Price Prediction) trades at $24.25, against a Wall Street consensus price target of $28.79, which represents implied upside of almost 19%.
3 of the Best Stocks to Buy for Less Than $100 Right Now
02:00pm, Tuesday, 14'th Jul 2026
These stocks offer a good mix of dividends, growth, and long-term stability.
Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen
11:51am, Tuesday, 14'th Jul 2026
Pfizer (NYSE: PFE | PFE Price Prediction) and Amgen (NASDAQ: AMGN) both reported Q1 2026 results this quarter, and the numbers reveal two very different bets on the future of oncology.
Here's How Pfizer's Oncology Growth Story Looks Ahead of Q2 Results
11:31am, Tuesday, 14'th Jul 2026
PFE's oncology business is in focus ahead of Q2 results as growth from key cancer drugs, biosimilars and pipeline updates may offset declines in older therapies.
Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?
10:24am, Tuesday, 14'th Jul 2026
The pharma giant's yield of around 7.1% is more than six times the S&P 500 average.
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
05:00am, Tuesday, 14'th Jul 2026
Voluntary pricing deals reduce uncertainty for major drugmakers. Drug pricing pressure won't affect every pharmaceutical company equally.
Pfizer (PFE) Advances While Market Declines: Some Information for Investors
06:45pm, Monday, 13'th Jul 2026
In the latest trading session, Pfizer (PFE) closed at $24.48, marking a +1.28% move from the previous day.
Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?
04:47pm, Monday, 13'th Jul 2026
Abbott Laboratories (NYSE: ABT | ABT Price Prediction) and Pfizer (NYSE: PFE) both delivered Q1 2026 beats, yet the market treats them differently.
